News REGENXBIO Announces Proposed Public Offering Of Common Stock ROCKVILLE, Md., Jan. 6, 2021 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the…Super UserJanuary 11, 2021
News Johns Hopkins Coronavirus Resource Center passes 1 billion views | Hub The Johns Hopkins Coronavirus Resource Center, a site launched in the spring of 2020 to offer critical data and perspective…Super UserJanuary 11, 2021
News Emergent BioSolutions Secures DOD Aid for Covid Treatment Test – TheStreet Emergent BioSolutions (EBS) - Get Report shares rose Wednesday after the life sciences company and Mount Sinai Health System announced a…Super UserJanuary 11, 2021
News Children’s National Hospital, NIH launch COVID-19 diagnostics AI challenge Washington, D.C.-based Children’s National Hospital is partnering with the National Institutes of Health and tech firm NVIDIA to launch a…Super UserJanuary 11, 2021
News CIT Announces Inaugural Solicitation for the New Commonwealth Commercialization Fund Richmond, VA, Jan. 07, 2021 (GLOBE NEWSWIRE) -- The Center for Innovative Technology (CIT) announced today its Request for Proposals…Super UserJanuary 11, 2021
News Healthcare Investments & Exits 2021 Annual Report | Silicon Valley Bank US healthcare venture fundraising soared in 2020, totaling $17B, a 57% increase over 2019’s record. Image: https://www.svb.com (more…)Super UserJanuary 11, 2021
News Behrman Capital’s Emmes acquires Neox Headquartered in Prague, Czech Republic, Neox is a CRO with over 150 employees who support biotechnology, pharmaceutical, and medical device…Super UserJanuary 11, 2021
News Maxcyte | Myeloid Therapeutics and MaxCyte Enter Clinical and Commercial Licensing Agreement to Advance Myeloid’s Cell Therapy Programs CAMBRIDGE, MA and GAITHERSBURG, MD, January 11, 2021 — Myeloid Therapeutics, Inc., a company harnessing and reprogramming yeloid cells to treat…Super UserJanuary 11, 2021
News Noble Life Sciences announces its collaboration with George Mason University to access the National Center for Biodefense and Infectious Diseases BSL-3 facility – BioHealth Capital Region Sykesville, MD, and Fairfax, VA, December 21, 2020 – Noble Life Sciences (NLS), a preclinical contract research organization located in Sykesville,…Super UserJanuary 11, 2021
News Baltimore’s Port Covington Ramps Up After Financing Boost With more than $650 million in financing in place, vertical construction in excess of 1.1 million square feet of mixed-use…Super UserJanuary 11, 2021